Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Ellman

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Structure activity studies of a novel cytotoxic benzodiazepineAnthony Boitano, Cory D Emal, Francesco Leonetti, et al.
Pain|August 14, 2015
Striatal-enriched protein tyrosine phosphatase modulates nociception: evidence from genetic deletion and pharmacological inhibitionGarikoitz Azkona, Ana Saavedra, Zigor Aira, et al.
Journal of Medicinal Chemistry|November 9, 2017
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase InhibitorsMichael R Witten, Lisa Wissler, Melanie Snow, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Tyrosylprotein sulfotransferase inhibitors generated by combinatorial target-guided ligand assemblyJohn W Kehoe, Dustin J Maly, Dawn E Verdugo, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2015
Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' diseaseR Jeffrey Neitz, Clifford Bryant, Steven Chen, et al.
Arthritis and Rheumatism|March 13, 2003
Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepineJeffrey J Bednarski, Roscoe E Warner, Tharaknath Rao, et al.
Chemistry & Biology|November 25, 2010
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease modelsMelissa J Leyva, Francesco Degiacomo, Linda S Kaltenbach, et al.
ACS Nano|February 4, 2010
Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensorsCheng Sun, Kai-Hung Su, Jason Valentine, et al.
Journal of Medicinal Chemistry|January 22, 2010
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapyKatrien Brak, Iain D Kerr, Kimberly T Barrett, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitorsZira T K Gannam, Haya Jamali, Oh Sang Kweon, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Structure activity studies of a novel cytotoxic benzodiazepineAnthony Boitano, Cory D Emal, Francesco Leonetti, et al.
Pain|August 14, 2015
Striatal-enriched protein tyrosine phosphatase modulates nociception: evidence from genetic deletion and pharmacological inhibitionGarikoitz Azkona, Ana Saavedra, Zigor Aira, et al.
Journal of Medicinal Chemistry|November 9, 2017
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase InhibitorsMichael R Witten, Lisa Wissler, Melanie Snow, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Tyrosylprotein sulfotransferase inhibitors generated by combinatorial target-guided ligand assemblyJohn W Kehoe, Dustin J Maly, Dawn E Verdugo, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2015
Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' diseaseR Jeffrey Neitz, Clifford Bryant, Steven Chen, et al.
Arthritis and Rheumatism|March 13, 2003
Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepineJeffrey J Bednarski, Roscoe E Warner, Tharaknath Rao, et al.
Chemistry & Biology|November 25, 2010
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease modelsMelissa J Leyva, Francesco Degiacomo, Linda S Kaltenbach, et al.
ACS Nano|February 4, 2010
Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensorsCheng Sun, Kai-Hung Su, Jason Valentine, et al.
Journal of Medicinal Chemistry|January 22, 2010
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapyKatrien Brak, Iain D Kerr, Kimberly T Barrett, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitorsZira T K Gannam, Haya Jamali, Oh Sang Kweon, et al.
Pageof 25